The National Hospital for Neurology and Neurosurgery is a neurological hospital in Queen Square, London. It is part of the University College London Hospitals NHS Foundation Trust. It was the first hospital to be established in England dedicated exclusively to treating the diseases of the nervous system.

There are 244 beds in Queen Square Centre for Neuromuscular Diseases.

During the past decade, Queen Square Centre for Neuromuscular Diseases conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Square Centre for Neuromuscular Diseases" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Reneo Pharma Ltd" with 2 trials sponsored, "Stealth BioTherapeutics Inc." with 2 trials sponsored, "University College London Hospitals" with 2 trials sponsored and "University College, London" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Queen Square Centre for Neuromuscular Diseases" are "Primary Mitochondrial Myopathy" (3 trials), "Multiple Sclerosis" (2 trials), "Distal Hereditary Motor Neuronopathy Type I" (1 trials), "Distal Hereditary Motor Neuronopathy Type VI" (1 trials) and "Distal Hereditary Motor Neuropathy, Type II" (1 trials). Many other conditions were trialed in "Queen Square Centre for Neuromuscular Diseases" in a lesser frequency.

Most popular intervention types in "Queen Square Centre for Neuromuscular Diseases" are "Drug" (7 trials), "Behavioral" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "REN001" (2 trials), "Antihistamine" (1 trials), "Bridges Self-management Support" (1 trials) and "Carbon Fibre Ankle Foot Orthosis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Square Centre for Neuromuscular Diseases" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Queen Square Centre for Neuromuscular Diseases". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Queen Square Centre for Neuromuscular Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Square Centre for Neuromuscular Diseases, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".